Quang T, Mostashari G, Berning E, Gopalan B, Lizarralde-Iragorri M, Lovins D
Biomed Opt Express. 2024; 15(8):4829-4841.
PMID: 39346999
PMC: 11427197.
DOI: 10.1364/BOE.527770.
Light J, Abrams C, Ilich A, Huang S, Zhu H, Baskin-Miller J
Res Pract Thromb Haemost. 2024; 8(4):102471.
PMID: 39099800
PMC: 11295566.
DOI: 10.1016/j.rpth.2024.102471.
Petiwathayakorn T, Paradee N, Hantrakool S, Jarujareet U, Intharah T, Srichairatanakool S
ACS Appl Bio Mater. 2024; 7(7):4710-4724.
PMID: 38920024
PMC: 11253095.
DOI: 10.1021/acsabm.4c00516.
Kato Y, Kominami T
Cureus. 2024; 16(5):e60653.
PMID: 38899256
PMC: 11185989.
DOI: 10.7759/cureus.60653.
Nagose V, Kodate P, Kumbhalkar D, Rathod S, Nayak S
Indian J Hematol Blood Transfus. 2024; 40(2):281-288.
PMID: 38708151
PMC: 11065820.
DOI: 10.1007/s12288-023-01703-9.
Syk inhibition suppresses NLRP3 inflammasome activation in platelets from sickle cell mice leading to decreased platelet secretion, aggregation, spreading, and in vitro thrombus formation.
Vogel S, Kamimura S, Smith M, Almeida L, Cui X, Combs C
Thromb Res. 2024; 237:18-22.
PMID: 38547689
PMC: 11614189.
DOI: 10.1016/j.thromres.2024.03.020.
VWF-ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxycarbamide vs blood transfusion.
Fogarty H, Ahmad A, Atiq F, Doherty D, Ward S, Karampini E
Blood Adv. 2023; 7(22):6974-6989.
PMID: 37773926
PMC: 10690561.
DOI: 10.1182/bloodadvances.2023010824.
Interventions for chronic kidney disease in people with sickle cell disease.
Roy N, Carpenter A, Dale-Harris I, Doree C, Estcourt L
Cochrane Database Syst Rev. 2023; 8:CD012380.
PMID: 37539955
PMC: 10404133.
DOI: 10.1002/14651858.CD012380.pub3.
Effect of a Physical Exercise Program on the Inflammatory Response, Cardiac Functions, Functional Capacity, and Quality of Life in Patients with Sickle Cell Disease.
Antonelli Rossi D, De Araujo Junior J, Luvizutto G, Bazan R, Salmazo P, Modolo G
J Clin Med. 2023; 12(12).
PMID: 37373647
PMC: 10299033.
DOI: 10.3390/jcm12123952.
COVID-19 and Sickle Cell Disease: Two Independent Risk Factors for Venous Thromboembolism.
Saxena P, Muthu J
Cureus. 2023; 15(4):e37226.
PMID: 37159776
PMC: 10163976.
DOI: 10.7759/cureus.37226.
Intestinal barrier functions in hematologic and oncologic diseases.
Haroun E, Ashok Kumar P, Saba L, Kassab J, Ghimire K, Dutta D
J Transl Med. 2023; 21(1):233.
PMID: 37004099
PMC: 10064590.
DOI: 10.1186/s12967-023-04091-w.
The association between fasting plasma glucose variability and incident eGFR decline: evidence from two cohort studies.
Deravi N, Sharifi Y, Koohi F, Tamehri Zadeh S, Masrouri S, Azizi F
BMC Public Health. 2023; 23(1):565.
PMID: 36973769
PMC: 10041700.
DOI: 10.1186/s12889-023-15463-8.
The Role of Inflammation in The Cellular and Molecular Mechanisms of Cardiopulmonary Complications of Sickle Cell Disease.
Gbotosho O, Gollamudi J, Hyacinth H
Biomolecules. 2023; 13(2).
PMID: 36830749
PMC: 9953727.
DOI: 10.3390/biom13020381.
Factor XII contributes to thrombotic complications and vaso-occlusion in sickle cell disease.
Sparkenbaugh E, Henderson M, Miller-Awe M, Abrams C, Ilich A, Trebak F
Blood. 2023; 141(15):1871-1883.
PMID: 36706361
PMC: 10122107.
DOI: 10.1182/blood.2022017074.
Investigation of thrombin generation assay to predict vaso-occlusive crisis in adulthood with sickle cell disease.
Feugray G, Kasonga F, Grall M, Dumesnil C, Benhamou Y, Brunel V
Front Cardiovasc Med. 2022; 9:883812.
PMID: 36277754
PMC: 9579298.
DOI: 10.3389/fcvm.2022.883812.
Role of Serum Ferritin in Predicting Outcomes of COVID-19 Infection Among Sickle Cell Disease Patients: A Systematic Review and Meta-Analysis.
Lee J, Chieng W, Abdul Jalal M, Tan C, Lau S
Front Med (Lausanne). 2022; 9:919159.
PMID: 35712092
PMC: 9196080.
DOI: 10.3389/fmed.2022.919159.
Functional foods: promising therapeutics for Nigerian Children with sickle cell diseases.
Alabi O, Adegboyega F, Olawoyin D, Babatunde O
Heliyon. 2022; 8(6):e09630.
PMID: 35677416
PMC: 9167986.
DOI: 10.1016/j.heliyon.2022.e09630.
The endothelial glycocalyx in critical illness: A pediatric perspective.
Richter R, Payne G, Ambalavanan N, Gaggar A, Richter J
Matrix Biol Plus. 2022; 14:100106.
PMID: 35392182
PMC: 8981764.
DOI: 10.1016/j.mbplus.2022.100106.
Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy.
Graziadei G, De Franceschi L, Sainati L, Venturelli D, Masera N, Bonomo P
Front Med (Lausanne). 2022; 9:832154.
PMID: 35372393
PMC: 8967327.
DOI: 10.3389/fmed.2022.832154.
A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease.
Zaidi A, Glaros A, Lee S, Wang T, Bhojwani R, Morris E
Orphanet J Rare Dis. 2021; 16(1):460.
PMID: 34727959
PMC: 8561926.
DOI: 10.1186/s13023-021-02096-6.